Pivot Insulin Delivery System
Modular Medical, Inc. · Decision date Sep 2, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on September 2, 2026 for the Pivot Insulin Delivery System, a Class II infusion pump (21 CFR 880.5725, product code LZG) submitted by Modular Medical, Inc. of San Diego, California, under 510(k) number K262153. The submission was received June 26, 2026 as a Traditional 510(k) reviewed by the Clinical Chemistry panel within the General Hospital specialty; it was not reviewed by a third party and no predetermined change control plan was authorized. SESE denotes 510(k) clearance, not premarket approval.
The filing is a modification of the previously cleared Pivot Insulin Delivery System (K253534), with indications for use stated as unchanged. The listed changes are user-selectable bolus increment settings, updated Controller and Pivot Diabetes App software, minor Controller hardware updates for manufacturability, and related labeling updates. The summary states programmable basal rates of 0.5 to 4.0 units per hour in 0.1-unit increments and a 20-unit maximum individual bolus. The summary does not disclose the specific bolus increment values, detailed test results, or the basis for the predicate's original clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General Hospital
- Decision date
- Sep 2, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262153
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Modular Medical, Inc.
- Product code
- LZG
- Decision code
- SESE
- Decision date
- Sep 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Pump, Infusion, Insulin.
- Applicant
- Modular Medical, Inc.
- Product code
- LZG
- FDA device class
- 2
FDA decision timeline
K262153 received
Application receipt date recorded by FDA.
K262153 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Modular Medical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- San Diego, CA
Sources and methodology
- Original FDA record: K262153
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records